EP1539189A4

Method of using anti-apoptotic factors in gene expression

Abstract

This record has no abstract on file.

EP1539189A4, drawing sheet 1 — Sheet 1 of 10

Term

Term ended

Projected expiry passed 25 March 2023, 3.5 years ago.

10 sheets

Sheet 1
Sheet 2
Sheet 3
Sheet 4
Sheet 5
Sheet 6
Sheet 7
Sheet 8
Sheet 9
Sheet 10

Every citation, both waysCites: the store holds 1 of 2

Citations
Document	Relation	Office	Category	Cited during	Relevant claims
US6207648B1	Cites	United States of America	Y	Search report	2-18,31
LUO ZHENGYU ET AL: "Enhancement of Fas ligand-induced inhibition of neointimal formation in rabbit femoral and iliac arteries by coexpression of p35", HUMAN GENE THERAPY, vol. 12, no. 18, 10 December 2001 (2001-12-10), pages 2191 - 2202, XP002425299, ISSN: 1043-0342	Non-patent	–	–	Search report	–
SCHWARTZ P C ET AL: "Enhanced bystander cytotoxicity of P450 gene-directed enzyme prodrug therapy by expression of the antiapoptotic factor p35", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 62, 1 December 2002 (2002-12-01), pages 6928 - 6937, XP002973773, ISSN: 0008-5472	Non-patent	–	–	Search report	–
DATABASE EMBASE [online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; 15 December 2003 (2003-12-15), WAXMAN D J ET AL: "Harnessing Apoptosis for Improved Anticancer Gene Therapy", XP002425302, Database accession no. EMB-2004023656	Non-patent	–	–	Search report	–
SCHWARTZ PAMELA S ET AL: "Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells", MOLECULAR PHARMACOLOGY, vol. 60, no. 6, December 2001 (2001-12-01), pages 1268 - 1279, XP002425300, ISSN: 0026-895X	Non-patent	–	–	Search report	–

7 members in 4 offices

This recordMember, by publication datePriority claim

Priority claims9

Priority claims
Document	Office	Kind	Date
367311P	United States of America	–	2002-03-25
36731102	United States of America	P	2002-03-25
36731102	United States of America	P	2002-03-25
0308743	United States of America	W	2003-03-25
0308743	United States of America	W	2003-03-25
367311P	–	–	–
US20020367311P	–	–	–
US2003008743	–	–	–
WO2003US08743	–	–	–

Members7

Family members, oldest first
Document	Office	Kind
WO03083052A2	World Intellectual Property Organization (WIPO)	A2	2003-10-09
AU2003224732A1	Australia	A1	2003-10-13
AU2003224732A8	Australia	A8	2003-10-13
WO03083052A3	World Intellectual Property Organization (WIPO)	A3	2004-03-04
EP1539189A2	European Patent Office (EPO)	A2	2005-06-15
US2006057109A1	United States of America	A1	2006-03-16
EP1539189A4This record	European Patent Office (EPO)	A4	2007-05-09

12 legal events, as the office reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code
2012-03-28	Application deemed to be withdrawnWithdrawn18D	18D
2012-02-24	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA	STAA
2007-12-26	First examination report despatched17Q	17Q
2007-05-09	Supplementary search report drawn up and despatchedA4	A4
2007-04-25	Information provided on ipc code assigned before grantRIC1	RIC1
2007-04-25	Information provided on ipc code assigned before grantRIC1	RIC1
2007-04-25	Information provided on ipc code assigned before grantRIC1	RIC1
2007-04-25	Information provided on ipc code assigned before grantRIC1	RIC1
2005-06-15	Request for examination filed17P	17P
2005-06-15	Designated contracting statesAK	AK
2005-06-15	Request for extension of the european patentAX	AX
2005-04-29	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI